Skip to main content
. 2022 Aug 2;15:28. doi: 10.1186/s13072-022-00460-9

Table 2.

Distributions of maternal and fetal participant and sample characteristics for those with placenta DNA methylation measures, split by maternal use of prenatal vitamins in month 1 of pregnancy

MARBLES EARLI
No use of prenatal vitamins month 1 Use of prenatal vitamins month 1 P-value No use of prenatal vitamins month 1 Use of prenatal vitamins month 1 P-value
N = 37 N = 33 N = 35 N = 53
Maternal education
 No degree 21 (56.8%) 10 (30.3%) 0.05 17 (48.6%) 19 (35.8%) 0.33
 College degree 16 (43.2%) 23 (69.7%) 18 (51.4%) 34 (64.2%)
Maternal age at delivery (years) 35.3 (5.16) 35.1 (5.86) 0.89 33.8 (4.46) 33.5 (4.75) 0.77
Maternal pre-pregnancy BMI 29.0 (8.21) 26.4 (5.86) 0.12 26.8 (5.90) 27.9 (8.20) 0.47
Child race/ethnicity
 Non-Hispanic White 16 (43.2%) 8 (24.2%) 0.11 16 (45.7%) 25 (47.2%) 0.34
 Hispanic 14 (37.8%) 12 (36.4%) 5 (14.3%) 11 (20.8%)
 Other/multiple 7 (18.9%) 13 (39.4%) 14 (40.0%) 17 (32.1%)
Child sex
 Female 17 (45.9%) 7 (21.2%) 0.05 18 (51.4%) 17 (32.1%) 0.11
 Male 20 (54.1%) 26 (78.8%) 17 (48.6%) 36 (67.9%)
Gestational age at delivery (weeks) 39.4 (1.14) 39.2 (0.83) 0.49 39.1 (1.59) 39.4 (1.22) 0.39
Estimated cell proportion
 Trophoblasts 14.0 (7.55) 15.2 (6.14) 0.47 13.0 (6.04) 14.4 (5.13) 0.27
 Stromal 9.06 (6.41) 10.0 (6.26) 0.52 10.3 (3.75) 9.47 (3.51) 0.31
 Hofbauer 4.71 (2.22) 4.24 (2.22) 0.37 2.73 (1.45) 2.77 (1.54) 0.89
 Endothelial 5.43 (2.22) 7.25 (3.68) 0.02 5.57 (2.45) 6.05 (2.63) 0.38
 nRBC 0.80 (1.05) 0.55 (1.02) 0.32 1.24 (1.00) 1.46 (2.11) 0.51
 Syncytiotrophoblast 66.0 (12.6) 62.8 (9.74) 0.23 67.1 (9.18) 65.9 (8.63) 0.51
Mean DNA methylation
 Overall 53.3 (1.09) 52.8 (1.12) 0.05 45.0 (1.04) 44.5 (1.15) 0.03
 Open sea 65.3 (1.41) 64.7 (1.49) 0.06 62.1 (1.17) 61.6 (1.48) 0.09
 CpG shelf 69.2 (1.26) 68.5 (1.50) 0.06 68.4 (1.29) 67.8 (1.61) 0.11
 CpG shore 45.5 (1.12) 45.0 (1.09) 0.06 42.7 (1.17) 42.1 (1.14) 0.02
 CpG island 18.7 (0.69) 18.6 (0.70) 0.64 20.1 (1.00) 19.6 (0.92) 0.02
DNA methylation laboratory batch1
 1 32 (91.4%) 46 (86.8%) 0.73
 2 3 (8.57%) 7 (13.2%)

1The EARLI and MARBLES samples were run separately. In EARLI placenta batch represents two different runs, MARBLES placenta were measured in a single run on single plate